{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T04:18:08Z","timestamp":1783570688631,"version":"3.55.0"},"reference-count":47,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Amyloid PET is increasingly used to confirm cerebral amyloid burden, but standard acquisition may be compromised by head motion, limited patient cooperation, reduced effective counts, premature scan termination, or non-repeatable imaging conditions. This comprehensive narrative review used a structured evidence-mapping approach in accordance with SANRA quality criteria. A structured literature search was performed in PubMed\/MEDLINE, Scopus, and Web of Science up to 15 March 2026. Eligible studies included clinical, phantom, or hybrid studies addressing acquisition-time reduction, injected-activity reduction or low-count imaging, motion correction, or artificial intelligence-based image enhancement. Findings were synthesized narratively because of substantial heterogeneity in tracers, scanners, protocols, reconstruction methods, populations, comparators, and endpoints. Sixteen studies were included. Moderate reductions in acquisition time or effective counts generally preserved semiquantitative performance, whereas visual interpretation became more vulnerable under more aggressive reductions, borderline amyloid status, or reduced image quality. Artificial intelligence-based restoration improved image-quality metrics and supported interpretation of short- or low-count acquisitions, but evidence remained model-specific. Motion correction was supported by one amyloid-specific [18F]flutemetamol PET\/CT study and should be interpreted as a potentially useful but under-replicated strategy. Current evidence supports cautious, tracer-, scanner-, reconstruction-, and task-specific optimization under challenging acquisition conditions rather than universal protocol reduction or direct generalization to motion-prone, poorly cooperative, or non-repeatable acquisition scenario. Reduced protocols, artificial intelligence-based restoration, and motion correction should remain locally validated supportive strategies, not substitutes for standard acquisition.<\/jats:p>","DOI":"10.3390\/diagnostics16132033","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T15:27:37Z","timestamp":1782746857000},"page":"2033","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Technical Optimization Strategies for Amyloid PET Under Challenging Acquisition Conditions: A Comprehensive Narrative Review"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1654-323X","authenticated-orcid":false,"given":"Luca","family":"Camoni","sequence":"first","affiliation":[{"name":"Allied Health and Social Care Professions Directorate, ASST Spedali Civili di Brescia, University of Brescia, 25123 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4839-9033","authenticated-orcid":false,"given":"Francesco","family":"Dondi","sequence":"additional","affiliation":[{"name":"Nuclear Medicine, ASST Spedali Civili di Brescia, University of Brescia, 25123 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0476-5655","authenticated-orcid":false,"given":"Agata","family":"Pietrzak","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Department, Greater Poland Cancer Centre, 61-866 Poznan, Poland"},{"name":"Electroradiology Department, Poznan University of Medical Sciences, 61-866 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9045-8514","authenticated-orcid":false,"given":"Roberto","family":"Rinaldi","sequence":"additional","affiliation":[{"name":"Nuclear Medicine, ASST Spedali Civili di Brescia, 25123 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Tomasoni","sequence":"additional","affiliation":[{"name":"Nuclear Medicine, ASST Spedali Civili di Brescia, 25123 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8448-2118","authenticated-orcid":false,"given":"Michela","family":"Cossandi","sequence":"additional","affiliation":[{"name":"Nuclear Medicine, ASST Spedali Civili di Brescia, 25123 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2161-491X","authenticated-orcid":false,"given":"Silvia","family":"Lucchini","sequence":"additional","affiliation":[{"name":"Nuclear Medicine, ASST Spedali Civili di Brescia, 25123 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Luca","family":"Vigan\u00f2","sequence":"additional","affiliation":[{"name":"Clinical Engineering, ASST Spedali Civili di Brescia, 25123 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8635-7411","authenticated-orcid":false,"given":"Luigi","family":"Spiazzi","sequence":"additional","affiliation":[{"name":"Health Physics Department, ASST Spedali Civili di Brescia, 25123 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bertagna","sequence":"additional","affiliation":[{"name":"Nuclear Medicine, ASST Spedali Civili di Brescia, University of Brescia, 25123 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: An analysis for the Global Burden of Disease Study 2019","volume":"7","author":"Nichols","year":"2022","journal-title":"Lancet Public Health"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Alzheimer\u2019s Association (2024). 2024 Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s Dement., 20, 3708\u20133821.","DOI":"10.1002\/alz.13809"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1002\/alz.12919","article-title":"CSF biomarker concordance with amyloid PET in Phase 3 studies of aducanumab","volume":"19","author":"Nisenbaum","year":"2023","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Rabinovici, G.D., Selkoe, D.J., Schindler, S.E., Aisen, P., Apostolova, L.G., Atri, A., Greenberg, S.M., Hendrix, S.B., Petersen, R.C., and Weiner, M. (2025). Donanemab: Appropriate use recommendations. J. Prev. Alzheimer\u2019s Dis., 12.","DOI":"10.1016\/j.tjpad.2025.100150"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in Early Alzheimer\u2019s Disease","volume":"388","author":"Swanson","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"476","DOI":"10.2967\/jnumed.113.120618","article-title":"Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer\u2019s Association","volume":"54","author":"Johnson","year":"2013","journal-title":"J. Nucl. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.2967\/jnumed.124.268756","article-title":"Updated Appropriate Use Criteria for Amyloid and Tau PET: A Report from the Alzheimer\u2019s Association and Society for Nuclear Medicine and Molecular Imaging Workgroup","volume":"66","author":"Rabinovici","year":"2025","journal-title":"J. Nucl. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.2967\/jnumed.116.174615","article-title":"SNMMI Procedure Standard\/EANM Practice Guideline for Amyloid PET Imaging of the Brain 1.0","volume":"57","author":"Minoshima","year":"2016","journal-title":"J. Nucl. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s00259-015-3228-x","article-title":"Diagnostic accuracy of 18F amyloid PET tracers for the diagnosis of Alzheimer\u2019s disease: A systematic review and meta-analysis","volume":"43","author":"Morris","year":"2016","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s00259-021-05603-w","article-title":"EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3","volume":"49","author":"Guedj","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"670","DOI":"10.2967\/jnumed.123.265766","article-title":"Quantitative Brain Amyloid PET","volume":"65","author":"Jagust","year":"2024","journal-title":"J. Nucl. Med."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Kamitaka, Y., Sakata, M., Oda, K., Katsuki, A., Kawakami, H., Wagatsuma, K., Kobayashi, M., and Ishii, K. (2025). Quantitative validation of data-driven motion correction for brain PET using phantom with motion generator system. EJNMMI Phys., 13.","DOI":"10.1186\/s40658-025-00820-w"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1002\/hbm.24497","article-title":"MR-PET head motion correction based on co-registration of multicontrast MR images","volume":"42","author":"Chen","year":"2021","journal-title":"Hum. Brain Mapp."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1007\/s00259-017-3675-7","article-title":"Consequences of radiopharmaceutical extravasation and therapeutic interventions: A systematic review","volume":"44","author":"Bucerius","year":"2017","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e636","DOI":"10.1200\/JOP.19.00302","article-title":"Assessing and Reducing Positron Emission Tomography\/Computed Tomography Radiotracer Infiltrations: Lessons in Quality Improvement and Sustainability","volume":"16","author":"Kiser","year":"2020","journal-title":"JCO Oncol. Pract."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1053\/j.semnuclmed.2018.02.006","article-title":"Innovations in Instrumentation for Positron Emission Tomography","volume":"48","author":"Berg","year":"2018","journal-title":"Semin. Nucl. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejmp.2015.12.007","article-title":"Advances in time-of-flight PET","volume":"32","author":"Surti","year":"2016","journal-title":"Phys. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1148\/radiol.2017162305","article-title":"Reduction of 18F-FDG Dose in Clinical PET\/MR Imaging by Using Silicon Photomultiplier Detectors","volume":"286","author":"Sekine","year":"2018","journal-title":"Radiology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"348","DOI":"10.2967\/jnumed.125.269540","article-title":"Nuclear Medicine AI in Action: The Bethesda Report (AI Summit 2024)","volume":"67","author":"Rahmim","year":"2026","journal-title":"J. Nucl. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1053\/j.semnuclmed.2025.01.006","article-title":"The Evolution of Artificial Intelligence in Nuclear Medicine","volume":"55","author":"Lopes","year":"2025","journal-title":"Semin. Nucl. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"5468","DOI":"10.1002\/mp.17068","article-title":"Full-dose whole-body PET synthesis from low-dose PET using high-efficiency denoising diffusion probabilistic model: PET consistency model","volume":"51","author":"Pan","year":"2024","journal-title":"Med. Phys."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12194-024-00780-3","article-title":"Deep learning-based PET image denoising and reconstruction: A review","volume":"17","author":"Hashimoto","year":"2024","journal-title":"Radiol. Phys. Technol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Baethge, C., Goldbeck-Wood, S., and Mertens, S. (2019). SANRA-a scale for the quality assessment of narrative review articles. Res. Integr. Peer Rev., 4.","DOI":"10.1186\/s41073-019-0064-8"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s00259-012-2268-8","article-title":"Influence of scan duration on the accuracy of \u03b2-amyloid PET with florbetaben in patients with Alzheimer\u2019s disease and healthy volunteers","volume":"40","author":"Tiepolt","year":"2013","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1007\/s12149-021-01634-3","article-title":"Effect of different examination conditions on image quality and quantitative value of amyloid positron emission tomography using 18F-flutemetamol","volume":"35","author":"Otani","year":"2021","journal-title":"Ann. Nucl. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s12194-022-00653-7","article-title":"Decreased imaging time of amyloid PET using [18F]florbetapir can maintain quantitative accuracy","volume":"15","author":"Wagatsuma","year":"2022","journal-title":"Radiol. Phys. Technol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"7765","DOI":"10.21037\/qims-23-268","article-title":"The image quality, amyloid-\u03b2 detectability, and acquisition time of clinical florbetapir positron emission tomography in Alzheimer\u2019s disease and healthy adults","volume":"13","author":"Xie","year":"2023","journal-title":"Quant. Imaging Med. Surg."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Trinh, P.T.H., Kim, D.Y., Choi, K.H., and Kim, J. (2024). Impact of shortening time on diagnosis of 18F-florbetaben PET. EJNMMI Res., 14.","DOI":"10.1186\/s13550-024-01181-8"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Yang, X., Wu, M., Liang, M., Zhang, H., Li, B., Mao, C., Dong, L., Wang, Y., Xing, H., and Ren, C. (2024). Ultra-fast [18F]florbetapir PET imaging using the uMI Panorama PET\/CT system. EJNMMI Phys., 11.","DOI":"10.1186\/s40658-024-00712-5"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"378","DOI":"10.2967\/jnumed.111.090340","article-title":"Performance characteristics of amyloid PET with florbetapir F 18 in patients with alzheimer\u2019s disease and cognitively normal subjects","volume":"53","author":"Joshi","year":"2012","journal-title":"J. Nucl. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1007\/s00259-014-2842-3","article-title":"The effect of 18F-florbetapir dose reduction on region-based classification of cortical amyloid deposition","volume":"41","author":"Herholz","year":"2014","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1007\/s00259-023-06481-0","article-title":"Impact of simulated reduced injected dose on the assessment of amyloid PET scans","volume":"51","author":"Young","year":"2024","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1148\/radiol.2018180940","article-title":"Ultra-Low-Dose 18F-Florbetaben Amyloid PET Imaging Using Deep Learning with Multi-Contrast MRI Inputs","volume":"290","author":"Chen","year":"2019","journal-title":"Radiology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1007\/s00259-020-05151-9","article-title":"True ultra-low-dose amyloid PET\/MRI enhanced with deep learning for clinical interpretation","volume":"48","author":"Chen","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3174\/ajnr.A7410","article-title":"Investigating Simultaneity for Deep Learning-Enhanced Actual Ultra-Low-Dose Amyloid PET\/MR Imaging","volume":"43","author":"Chen","year":"2022","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1097\/RLU.0000000000003471","article-title":"PET\/CT for Brain Amyloid: A Feasibility Study for Scan Time Reduction by Deep Learning","volume":"46","author":"Lee","year":"2021","journal-title":"Clin. Nucl. Med."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Jeong, Y.J., Park, H.S., Jeong, J.E., Yoon, H.J., Jeon, K., Cho, K., and Kang, D.Y. (2021). Restoration of amyloid PET images obtained with short-time data using a generative adversarial networks framework. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-84358-8"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Peng, Z., Ni, M., Shan, H., Lu, Y., Li, Y., Zhang, Y., Pei, X., Chen, Z., Xie, Q., and Wang, S. (2021). Feasibility evaluation of PET scan-time reduction for diagnosing amyloid-\u03b2 levels in Alzheimer\u2019s disease patients using a deep-learning-based denoising algorithm. Comput. Biol. Med., 138.","DOI":"10.1016\/j.compbiomed.2021.104919"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Park, H.L., Park, S.Y., Kim, M., Paeng, S., Min, E.J., Hong, I., Jones, J., and Han, E.J. (2024). Improving diagnostic precision in amyloid brain PET imaging through data-driven motion correction. EJNMMI Phys., 11.","DOI":"10.1186\/s40658-024-00653-z"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2967\/jnumed.111.095240","article-title":"Methods for motion correction evaluation using 18F-FDG human brain scans on a high-resolution PET scanner","volume":"53","author":"Keller","year":"2012","journal-title":"J. Nucl. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.2967\/jnumed.121.263309","article-title":"Evaluation of Data-Driven Rigid Motion Correction in Clinical Brain PET Imaging","volume":"63","author":"Hurley","year":"2022","journal-title":"J. Nucl. Med."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Revilla, E.M., Gallezot, J.D., Naganawa, M., Toyonaga, T., Fontaine, K., Mulnix, T., Onofrey, J.A., Carson, R.E., and Lu, Y. (2022). Adaptive data-driven motion detection and optimized correction for brain PET. Neuroimage, 252.","DOI":"10.1016\/j.neuroimage.2022.119031"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1007\/s12149-022-01774-0","article-title":"Brain PET motion correction using 3D face-shape model: The first clinical study","volume":"36","author":"Iwao","year":"2022","journal-title":"Ann. Nucl. Med."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Tiss, A., Marin, T., Chemli, Y., Spangler-Bickell, M., Gong, K., Lois, C., Petibon, Y., Landes, V., Grogg, K., and Normandin, M. (2023). Impact of motion correction on [18F]-MK6240 tau PET imaging. Phys. Med. Biol., 68.","DOI":"10.1088\/1361-6560\/acd161"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1109\/TRPMS.2024.3432322","article-title":"Effects of List-Mode-Based Intraframe Motion Correction in Dynamic Brain PET Imaging","volume":"8","author":"Tiss","year":"2024","journal-title":"IEEE Trans. Radiat. Plasma Med. Sci."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Yu, X., Hu, D., Yao, Q., Fu, Y., Zhong, Y., Wang, J., Tian, M., and Zhang, H. (2025). Diffused Multi-scale Generative Adversarial Network for low-dose PET images reconstruction. Biomed. Eng. Online, 24.","DOI":"10.1186\/s12938-025-01348-x"}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/13\/2033\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T04:12:38Z","timestamp":1783570358000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/13\/2033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":47,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["diagnostics16132033"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics16132033","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]}}}